Segment Information (Tables)

9 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Schedule of segment performance measures

Nine months Ended March 31, 2018 and 2017:

	Human Health			Pharmaceutical  Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2018
Net sales	$	301,407		$	113,406	$	127,669	$	-		$	542,482
Gross profit		57,080			17,259		27,310		-			101,649
(Loss) income before income taxes		(258,172	)*		5,795		14,121		(23,142	)		(261,398	)
2017
Net sales	$	201,686		$	121,253	$	120,759	$	-		$	443,698
Gross profit		56,424			19,867		27,672		-			103,963
Income (loss) before income taxes		13,912			7,299		13,599		(20,452	)		14,358

* Includes goodwill impairment charge of $235,110. See Note 9 Fair Value Measurements for details.

Three months Ended March 31, 2018 and 2017:

	Human  Health			Pharmaceutical  Ingredients		Performance Chemicals		Unallocated  Corporate			Consolidated  Totals
2018
Net sales	$	91,926		$	43,201	$	50,871	$	-		$	185,998
Gross profit		9,535			7,038		11,123		-			27,696
(Loss) income before income taxes		(265,486	)*		2,987		6,699		(7,237	)		(263,037	)
2017
Net sales	$	99,816		$	43,821	$	46,491	$	-		$	190,128
Gross profit		25,300			7,255		9,764		-			42,319
Income (loss) before income taxes		5,007			3,036		5,034		(4,565	)		8,512

* Includes goodwill impairment charge of $235,110. See Note 9 Fair Value Measurements for details.